A Safety and Efficacy Study to Evaluate AMG 334 in Migraine Prevention

NCT02630459 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
475
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen